Your browser doesn't support javascript.
loading
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.
Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T.
Afiliação
  • Kim DW; Seoul National University Hospital, Seoul, Korea.
  • Mehra R; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Tan DSW; National Cancer Center, Singapore, Singapore.
  • Felip E; Vall d'Hebron University, Barcelona, Spain.
  • Chow LQM; University of Washington, Seattle, WA, USA.
  • Camidge DR; University of Colorado, Denver, CO, USA.
  • Vansteenkiste J; University Hospital KU Leuven, Leuven, Belgium.
  • Sharma S; Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • De Pas T; Istituto Europeo di Oncologia, Milan, Italy.
  • Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Solomon BJ; Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
  • Wolf J; Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Thomas M; Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
  • Schuler M; University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany.
  • Liu G; Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Santoro A; IRCCS Institute Clinico Humanitas, Milan, Italy.
  • Sutradhar S; Novartis Pharma, East Hanover, NJ, USA.
  • Li S; Novartis Pharma, East Hanover, NJ, USA.
  • Szczudlo T; Novartis Pharma, East Hanover, NJ, USA.
  • Yovine A; Novartis Pharma AG, Basel, Switzerland.
  • Shaw AT; Massachusetts General Hospital, Boston, MA, USA. Electronic address: ashaw1@partners.org.
Lancet Oncol ; 17(4): 452-463, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26973324
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Receptores Proteína Tirosina Quinases / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonas / Receptores Proteína Tirosina Quinases / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article